Sugi Predict

Sugi Predict / Compounds / SCHEMBL1957035

SCHEMBL1957035

SCHEMBL1957035

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C3=CCC4CC(O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 1.00
▸ MEN1 O00255 2/20 1.00
▸ KMT2A Q03164 2/20 1.00
▸ ALDH1A1 P00352 2/20 1.00
▸ MAPT P10636 1/20 1.00
▸ ALOX15 P16050 1/20 1.00
▸ DHCR24 Q15392 10/20 0.77
▸ TRPV1 Q8NER1 1/20 0.61
▸ LMNA P02545 2/20 0.51
▸ NPC1L1 Q9UHC9 1/20 0.51
▸ RORC P51449 2/20 0.50
▸ ABCB1 P08183 1/20 0.50
▸ OSBP P22059 1/20 0.50
▸ OSBP2 Q969R2 1/20 0.50
▸ CYP46A1 Q9Y6A2 1/20 0.50
▸ THRB P10828 1/20 0.49
▸ CYP8B1 Q9UNU6 1/20 0.48
▸ GPR183 P32249 1/20 0.46
▸ RORA P35398 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL187737 1.00 USP2 (1.00) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL14360754 1.00 USP2 (1.00) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL22099724 1.00 USP2 (1.00) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL15529878 1.00 USP2 (1.00) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL5571689 1.00 USP2 (1.00) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL28606202 1.00 USP2 (1.00) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL25035233 1.00 USP2 (1.00) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL28186368 0.92 MEN1 (0.85) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL12869826 0.91 MEN1 (0.83) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL12869831 0.91 MEN1 (0.83) USP2MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119979588-A Sterol C24-reductase mutant capable of reducing byproducts and saccharomyces cerevisiae capable of producing 7-dehydrocholesterol 江南大学 2025-05-13 — — CN claimed
US-20240335458-A1 OPHTHALMIC COMPOSITION FOR THE TREATMENT OF VISUAL DISORDERS FOODVICA, S.A. DE C.V. (MX) 2024-10-10 — — US claimed
EP-4382098-A1 OPHTHALMIC COMPOSITION FOR THE TREATMENT OF VISUAL DISORDERS Foodvica, S.A. De C.V. (MX) 2024-06-12 — — EP claimed
WO-2023012754-A1 OPHTHALMIC COMPOSITION FOR THE TREATMENT OF VISUAL DISORDERS FOODVICA, S.A. DE C.V. (MX) 2023-02-09 — — WO claimed
CN-109528806-B Sterol composition in pumpkin seed oil, application thereof and medicine for treating prostatic hyperplasia 刘东波 2021-08-06 — — CN claimed
US-20210222222-A1 OPTIMIZATION OF C-5 STEROL DESATURATION DSM IP ASSETS B.V. (NL) 2021-07-22 — — US claimed
EP-3797168-A1 OPTIMIZATION OF C-5 STEROL DESATURATION DSM IP Assets B.V. (NL) 2021-03-31 — — EP claimed
EP-3328389-A1 COMPOSITIONS FOR THE TREATMENT OF CATARACTS Catacore, Inc. (US) 2018-06-06 — — EP claimed
US-20170027961-A1 COMPOSITIONS FOR THE TREATMENT OF CATARACTS Catacore, Inc. (US) 2017-02-02 — — US claimed
WO-2017019808-A1 COMPOSITIONS FOR THE TREATMENT OF CATARACTS CATACORE, INC (US) 2017-02-02 — — WO claimed
EP-1059851-B2 STABLE HOMOGENEOUS EMULSIFIER-FREE SUSPENSION, PREPARATION METHOD AND USES IN FOOD COMPOSITIONS GERVAIS DANONE SA (FR) 2013-04-17 — — EP claimed
EP-1059851-B1 STABLE HOMOGENEOUS EMULSIFIER-FREE SUSPENSION, PREPARATION METHOD AND USES IN FOOD COMPOSITIONS GERVAIS DANONE SA (FR) 2002-05-08 — — EP claimed
EP-1059851-A1 STABLE HOMOGENEOUS EMULSIFIER-FREE SUSPENSION, PREPARATION METHOD AND USES IN FOOD COMPOSITIONS COMPAGNIE GERVAIS-DANONE (FR) 2000-12-20 — — EP claimed
WO-1999044442-A1 STABLE HOMOGENEOUS EMULSIFIER-FREE SUSPENSION, PREPARATION METHOD AND USES IN FOOD COMPOSITIONS COMPAGNIE GERVAIS DANONE (FR) 1999-09-10 — — WO claimed
US-12630852-B2 Modified sterol acyltransferases DSM IP ASSETS B.V. (NL) 2026-05-19 — — US disclosed
CN-119979588-B Sterol C24-reductase mutant capable of reducing byproducts and saccharomyces cerevisiae capable of producing 7-dehydrocholesterol 江南大学 2025-12-26 — — CN disclosed
EP-3797158-B1 MODIFIED STEROL ACYLTRANSFERASES DSM IP ASSETS BV (NL) 2025-10-22 — — EP disclosed
WO-1999044442-A1 STABLE HOMOGENEOUS EMULSIFIER-FREE SUSPENSION, PREPARATION METHOD AND USES IN FOOD COMPOSITIONS COMPAGNIE GERVAIS DANONE (FR) 1999-09-10 — — WO disclosed
WO-1995005737-A1 ALCOHOL-BASED HAND DISINFECTANT WITH A SKIN CARE COMPONENT BODE CHEMIE GMBH & CO. (DE) 1995-03-02 — — WO disclosed
EP-0289636-A1 Emulsified or solubilized sterol composition ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1988-11-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170027961-A1 COMPOSITIONS FOR THE TREATMENT OF CATARACTS CYP46A1, DHCR7, NR1H3 USP2 3111/4885MEN1 3838/4885KMT2A 4239/4885
US-12630852-B2 Modified sterol acyltransferases CYP46A1, DHCR7, CYP2R1 USP2 2179/4885MEN1 2661/4885KMT2A 1479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback